Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Waters Completes Pharmaceutical Industry PDA Audit, Joins Audit Repository Center

By R&D Editors | September 30, 2003

Waters Completes Pharmaceutical Industry PDA Audit, Joins Audit Repository Center

Waters has successfully completed the PDA Pharmaceutical Industry Software Supplier Quality Audit. Conducted by independent, PDA-approved auditors, this evaluation allows Waters customers to meet the federal government requirements for companies that supply software solutions to the pharmaceutical industry. Following the PDA audit process, the auditors reviewed documented evidence of structural validation and assessed Waters compliance to the established Software Development Life Cycle (SDLC).

The results of Waters audit are available through the Audit Repository Center (ARC), a global information sharing venue licensed by the PDA. The PDA, a non-profit international association for pharmaceutical sciences and technology, created a six-step process for audit execution that is outlined in its Technical Report #32. This technical report was written by the PDA Supplier Auditing and Qualification Task Group &#151 comprised of pharmaceutical companies, suppliers, auditors and FDA members &#151 in response to an FDA challenge to create a standard method to assess the structural integrity of acquired software.

Pharmaceutical companies must demonstrate compliance with industry regulations, such as the Food and Drug Administration’s 21 CFT Part 211.86 and 21 CFR Part 11. It is both costly and time consuming to show compliance with the audit requirements. By making the results of Waters software audit available through ARC (www.auditcenter.com), Waters customers do not need to conduct their own on-site audits, saving significant time and money.

“Waters is pleased to offer a solution to enable our customers in the pharmaceutical industry to be more efficient in their evaluation and deployment process,” said Noor Malki, Regularly Affairs Manager at Waters. “The ARC audit process significantly reduces the audit burden on our customers.”

Waters audit report contains more than 110 pages of information detailing the objective evidence that was examined during the audit. The complete report is placed on a CD-Rom that can be mailed out to Waters customers, upon request and only through the ARC, within days. Highlighting Waters successful audit completion are the words of an audit veteran. “Waters received the highest marks of any company that I have audited in 20 years,” commented Phil Lofty, lead auditor of Watson Pharmaceutical and PDA-certified auditor.

Related Articles Read More >

Microsoft’s 4D geometric codes slash quantum errors by 1,000x
Berkeley Lab’s Dell and NVIDIA-powered ‘Doudna’ supercomputer to enable real-time data access for 11,000 researchers
QED-C outlines road map for merging quantum and AI
Quantum computing hardware advance slashes superinductor capacitance >60%, cutting substrate loss
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE